National Healthcare Properties (Nasdaq: NHP) completed its initial public offering on April 22, 2026, pricing 38.5 million shares at $12.00 each. The stock opened at $11.56 — 3.7% below the offering price — before recovering to close at $12.19 on its second day of trading.
The underwriters, led by Wells Fargo, Morgan Stanley, and BMO Capital Markets, were also granted a 30-day option to purchase an additional 5,775,000 shares. The offering raised approximately $462 million in gross proceeds for the former nontraded REIT.
Opening day weakness reflected demand concerns
The $11.56 opening price marked a disappointing debut for the healthcare REIT, which had already priced below its marketed range. The company initially targeted $13 to $16 per share before settling at $12 — a signal that institutional demand fell short of expectations.
The below-range pricing and weak open were consistent with market skepticism surrounding nontraded REIT conversions. Several healthcare REITs have faced similar challenges when transitioning from private to public markets, as investors apply public market valuation standards that often diverge from board-approved net asset values (NAV).
NHP’s second day recovery offers cautious optimism
The stock’s recovery to $12.19 on April 23 represents a modest 1.6% gain above the IPO price. While the bounce is encouraging for day-one buyers, it provides little comfort to legacy shareholders who paid the equivalent of $100 per share on a split-adjusted basis.
National Healthcare Properties’ board-approved NAV stood at $32.15 per share as of December 31, 2024. The current trading price of $12.19 represents a 62% discount to that valuation. The gap reflects both the market’s assessment of the portfolio and the risks associated with the company’s ongoing transition.
Legacy shareholders remain locked until October
Original investors who purchased Healthcare Trust Inc. shares at $25 each (equivalent to $100 post-reverse split) still cannot sell on Nasdaq. Legacy nontraded REIT shares are restricted from trading until they convert to Class A shares, which is expected on or about October 19, 2026 — 180 days after the IPO pricing date.
This lockup period means that the investors most affected by the 88% decline from original cost have no ability to exit their positions. They must wait six months while the stock finds its public market footing.
Portfolio transition adds uncertainty
National Healthcare Properties holds 37 senior housing communities (3,615 units) and 130 outpatient medical facilities across 29 states. The entire senior housing portfolio operates under RIDEA structures, meaning the company shares operating risk with property managers.
A pending letter of intent (LOI) to sell the outpatient medical portfolio for $528 million would concentrate the company’s revenue in senior housing — a sector with documented operational volatility. If completed, the sale would reshape the company’s risk profile significantly.
The company reported a net loss of $71.1 million for fiscal year 2025. Whether the public market valuation improves will depend largely on execution of the portfolio transition and the senior housing sector’s recovery trajectory.
American Healthcare REIT provides a comparison
American Healthcare REIT (NYSE: AHR) followed a similar path from nontraded REIT to public listing at $12 per share. AHR’s stock eventually recovered to $54.67 — well above its original cost basis — but required sustained operational performance and favorable sector conditions.
Whether NHP follows a similar recovery path remains uncertain. The company faces a later economic cycle, a larger discount to original cost, and an active portfolio restructuring. Investors watching this name should monitor lockup expiry in October and any developments on the outpatient facility sale.
Stay ahead with our weekly newsletter
Get stock picks, REIT analysis, and income strategy updates delivered to your inbox every week. Subscribe to the AlphaBetaStock newsletter for free.
